Commonwealth Equity Services’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-63,227	Closed	-$78K	–	4381
2025 Q2	$78K	Sell	63,227 -13,135	-17%	-$15.2K	﹤0.01%	4101
2025 Q1	$90K	Sell	76,362 -35	-0%	-$54	﹤0.01%	4007
2024 Q4	$140K	Sell	76,397 -14,924	-16%	-$29.1K	﹤0.01%	3848
2024 Q3	$155K	Buy	91,321 +78,531	+614%	+$129K	﹤0.01%	3785
2024 Q2	$18K	Sell	12,790 -1,080	-8%	-$2.18K	﹤0.01%	3977
2024 Q1	$52K	Sell	13,870 -1,589	-10%	-$9.3K	﹤0.01%	3886
2023 Q4	$152K	Sell	15,459 -454	-3%	-$3.71K	﹤0.01%	3598
2023 Q3	$133K	Sell	15,913 -667	-4%	-$7.62K	﹤0.01%	3510
2023 Q2	$221K	Hold	16,580	–	–	﹤0.01%	3317
2023 Q1	$192	Sell	16,580 -185	-1%	-$1.84K	﹤0.01%	3332
2022 Q4	$137K	Sell	16,765 -19,203	-53%	-$165K	﹤0.01%	3349
2022 Q3	$208K	Sell	35,968 -6,040	-14%	-$34.7K	﹤0.01%	3136
2022 Q2	$185K	Sell	42,008 -5,828	-12%	-$35.4K	﹤0.01%	3228
2022 Q1	$435K	Sell	47,836 -2,105	-4%	-$24.2K	﹤0.01%	2635
2021 Q4	$1.02M	Buy	49,941 +29,338	+142%	+$708K	﹤0.01%	1971
2021 Q3	$526K	Buy	20,603 +3,721	+22%	+$110K	﹤0.01%	2434
2021 Q2	$590K	Buy	16,882 +788	+5%	+$22.9K	﹤0.01%	2342
2021 Q1	$536K	Buy	16,094 +5,526	+52%	+$193K	﹤0.01%	2278
2020 Q4	$274K	Buy	+10,568	New	+$180K	﹤0.01%	2657